首站-论文投稿智能助手
典型文献
Targeting glutamine utilization to block metabolic adaptation of tumor cells under the stress of carboxyamidotriazole-induced nutrients unavailability
文献摘要:
Tumor cells have unique metabolic programming that is biologically distinct from that of corresponding normal cells.Resetting tumor metabolic programming is a promising strategy to amelio-rate drug resistance and improve the tumor microenvironment.Here,we show that carboxyamidotriazole(CAI),an anticancer drug,can function as a metabolic modulator that decreases glucose and lipid meta-bolism and increases the dependency of colon cancer cells on glutamine metabolism.CAI suppressed glucose and lipid metabolism utilization,causing inhibition of mitochondrial respiratory chain complex I,thus producing reactive oxygen species(ROS).In parallel,activation of the aryl hydrocarbon receptor(AhR)increased glutamine uptake via the transporter SLC1A5,which could activate the ROS-scavenging enzyme glutathione peroxidase.As a result,combined use of inhibitors of GLS/GDH1,CAI could effectively restrict colorectal cancer(CRC)energy metabolism.These data illuminate a new antitumor mechanism of CAI,suggesting a new strategy for CRC metabolic reprogramming treatment.
文献关键词:
作者姓名:
Jing Shi;Rui Ju;Hongting Gao;Yuqing Huang;Lei Guo;Dechang Zhang
作者机构:
Department of Pharmacology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences and School of Basic Medicine,Peking Union Medical College,Beijing 100005,China;Department of Pharmacy,Peking University Third Hospital,Beijing 100191,China
引用格式:
[1]Jing Shi;Rui Ju;Hongting Gao;Yuqing Huang;Lei Guo;Dechang Zhang-.Targeting glutamine utilization to block metabolic adaptation of tumor cells under the stress of carboxyamidotriazole-induced nutrients unavailability)[J].药学学报(英文版),2022(02):759-773
A类:
carboxyamidotriazole,Resetting,GDH1
B类:
Targeting,glutamine,utilization,block,metabolic,adaptation,cells,under,stress,induced,nutrients,unavailability,Tumor,have,unique,that,biologically,distinct,from,corresponding,normal,promising,strategy,amelio,drug,resistance,improve,microenvironment,Here,we,show,CAI,anticancer,function,modulator,decreases,glucose,lipid,increases,dependency,colon,metabolism,suppressed,causing,inhibition,mitochondrial,respiratory,chain,complex,thus,producing,reactive,oxygen,species,ROS,In,parallel,activation,aryl,hydrocarbon,receptor,AhR,increased,uptake,via,transporter,SLC1A5,which,could,activate,scavenging,enzyme,glutathione,peroxidase,result,combined,use,inhibitors,GLS,effectively,restrict,colorectal,CRC,energy,These,data,illuminate,new,antitumor,mechanism,suggesting,reprogramming,treatment
AB值:
0.628168
相似文献
A metabolic acidity-activatable calcium phosphate probe with fluorescence signal amplification capabilities for non-invasive imaging of tumor malignancy
Qian Jia;Ruili Zhang;Yongdong Wang;Haohao Yan;Zheng Li;Yanbin Feng;Yu Ji;ZUO Yang;Yang Yang;Kanyi Pu;Zhongliang Wang-Laboratory of Molecular Imaging and Translational Medicine (MITM),Engineering Research Center of Molecular & Neuroimaging,Ministry of Education,School of Life Science and Technology,Xidian University,Xi'an 710126,China;Department of Thoracic Surgery,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai 200433,China;School of Materials Science and Engineering,Tongji University,Shanghai 201804,China;School of Chemical and Biomedical Engineering,Nanyang Technological University,Singapore 637457,Singapore;Academy of Advanced Interdisciplinary Research,Xidian University,Xi'an 710071,China
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Yi Xiao;Ding Ma;Yun-Song Yang;Fan Yang;Jia-Han Ding;Yue Gong;Lin Jiang;Li-Ping Ge;Song-Yang Wu;Qiang Yu;Qing Zhang;Francois Bertucci;Qiuzhuang Sun;Xin Hu;Da-Qiang Li;Zhi-Ming Shao;Yi-Zhou Jiang-Key Laboratory of Breast Cancer in Shanghai,Department of Breast Surgery,Fudan University Shanghai Cancer Center;Department of Oncology,Shanghai Medical College,Fudan University,Shanghai,China;Human Phenome Institute,Fudan University,Shanghai,China;Department of Pathology,University of Texas Southwestern Medical Center,Dallas,TX,USA;Predictive Oncology team,Centre de Recherche en Cancérologie de Marseille(CRCM),INSERM UMR1068,CNRS UMR725,Aix-Marseille Université,Institut Paoli-Calmettes,Marseille,France;Department of Industrial Systems Engineering and Management,National University of Singapore,Singapore,Singapore
Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase
Wen Li;Li-ping Liao;Ning Song;Yan-jun Liu;Yi-luan Ding;Yuan-yuan Zhang;Xiao-ru Zhou;Zhong-ya Sun;Sen-hao Xiao;Hong-bo Wang;Jing Lu;Nai-xia Zhang;Hua-liang Jiang;Kai-xian Chen;Chuan-peng Liu;Jie Zheng;Ke-hao Zhao;Cheng Luo-School of Pharmacy,Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong,Yantai University,Yantai 264005,China;Drug Discovery and Design Center,the Center for Chemical Biology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Center of Immunological Diseases,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Gastroenterology,Xinhua Hospital,School of Medicine,Shanghai Jiaotong University,Shanghai 201210,China;Department of Analytical Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Life Science and Technology,Shanghai Tech University,Shanghai 201210,China;School of Life Science and Technology,Harbin Institute of Technology,Harbin 200092,China;Department of Pharmacology,College of Pharmacy,Fujian Medical University,Fuzhou 350108,China
Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming
Ping Wang;Jin-mei Jin;Xiao-hui Liang;Ming-zhu Yu;Chun Yang;Fei Huang;Hui Wu;Bei-bei Zhang;Xiao-yan Fei;Zheng-tao Wang;Ren Xu;Hai-lian Shi;Xiao-jun Wu-Shanghai Key Laboratory of Compound Chinese Medicines,The Ministry of Education(MOE)Key Laboratory for Standardization of Chinese Medicines,The SATCM Key Laboratory for New Resources&Quality Evaluation of Chinese Medicine,Research Center of Shanghai Traditional Chinese Medicine Standardization,Institute of Chinese Materia Medica,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Markey Cancer Center,Department of Pharmacology and Nutritional Sciences,University of Kentucky College of Medicine,Lexington,KY,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。